Discounted Cash Flow
Phibro Animal Health Corp.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $751.5m | $82.7m | $866.0k | 11.0% | $2.11 |
| 2017 | $764.3m (1.7%) | $64.6m (-21.9%) | $77.5m (8849.8%) | 8.5% (-23.2%) | $1.63 (-22.7%) |
| 2018 | $820.0m (7.3%) | $64.9m (0.4%) | $51.5m (-33.6%) | 7.9% (-6.4%) | $1.61 (-1.2%) |
| 2019 | $828.0m (1.0%) | $54.7m (-15.7%) | $17.3m (-66.4%) | 6.6% (-16.5%) | $1.35 (-16.1%) |
| 2020 | $800.4m (-3.3%) | $33.6m (-38.7%) | $25.3m (46.4%) | 4.2% (-36.6%) | $0.83 (-38.5%) |
| 2021 | $833.4m (4.1%) | $54.4m (62.1%) | $19.0m (-25.0%) | 6.5% (55.7%) | $1.34 (61.4%) |
| 2022 | $942.3m (13.1%) | $49.2m (-9.6%) | $-5.4m (-128.4%) | 5.2% (-20.0%) | $1.21 (-9.7%) |
| 2023 | $977.9m (3.8%) | $32.6m (-33.7%) | $-38.5m (-613.3%) | 3.3% (-36.1%) | $0.81 (-33.1%) |
| 2024 | $1.0b (4.1%) | $2.4m (-92.6%) | $46.4m (220.5%) | 0.2% (-92.9%) | $0.06 (-92.6%) |
| 2025 | $1.3b (27.4%) | $48.3m (1897.7%) | $41.8m (-9.8%) | 3.7% (1468.4%) | $1.19 (1883.3%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.